
News|Articles|May 1, 2002
Plavix (clopidogrel bisulfate tablets), Sanofi-Synthelabo/Bristol-Myers Squibb
New Indication: Antiplatelet approved for acute coronary syndrome
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
FDA approves Simtriyo, the first triple reuptake inhibitor for ADHD
2
Long-acting HIV treatment still out of reach in low- and middle-income countries, says UCSF's Monica Gandhi | AIDS 2026
3
Long-acting cabotegravir PrEP users report no HIV infections, high satisfaction | AIDS 2026
4
Scientifically, lenacapavir PrEP takes a victory lap. But now worries about access | AIDS 2026
5


























